Germany Advises Proactive Measures for Platelet Transfusion Safety with Pathogen Inactivation

Cerus (CERS) announced a new recommendation from the German National Blood Advisory Committee, which recommends pathogen inactivation, such as Intercept, to enhance platelet transfusion safety. The committee suggests proactive measures, including pathogen inactivation, to address the residual risk of transfusion-transmitted bacterial infections. Intercept Blood System for Platelets eliminates the risk of false negatives and is widely adopted in countries like France and Switzerland, significantly reducing transfusion-related sepsis.